Catheter Precision Free Cash Flow (FCF) History (VTAK)

Catheter Precision reported −$8.3M in free cash flow for fiscal 2025, an increase of $1.0M from the previous fiscal year, with a free cash flow margin of −1015.02%.

View full Catheter Precision company overview

Catheter Precision free cash flow by year

Catheter Precision annual free cash flow

Fiscal yearPeriod endedFree cash flowChangeGrowthFCF margin
20252025-12-31−$8.3M$1.0M−1015.02%
20242024-12-31−$9.3M$11.4M−2223.33%
20232023-12-31−$20.7M$1.9M−4682.13%
20222022-12-31−$22.6M$5.3M−161321.43%
20212021-12-31−$27.9M$481,000−126772.73%
20202020-12-31−$28.4M$5.1M−10954.05%
20192019-12-31−$33.4M−$14.4M−464.52%
20182018-12-31−$19.1M−$13.0M−305.10%
20172017-12-31−$6.1M−103.41%

Catheter Precision free cash flow growth trends

Over the last five reported fiscal years, free cash flow grew from −$28.4M to −$8.3M, a net increase of $20.1M. Catheter Precision's latest reported quarter, Q2 2026, generated −$2.9M in free cash flow, a decrease of $606,000 year over year.

About the metric

What free cash flow means

Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.

Calculation and source

How free cash flow is calculated

TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.

Review Catheter Precision filings at SEC.gov ↗